Anticancer activities of histone deacetylase inhibitors
2006
Johnstone and colleagues discuss the molecular events that underlie the anticancer effects of histone deacetylase inhibitors, and consider how the clinical development and application of these agents may be optimized, either as monotherapies or in combination with other anticancer drugs.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
209
References
2427
Citations
NaN
KQI